Cancer treatments often require infusion treatments, like chemotherapy.?
This report aims to provide a comprehensive presentation of the global market for Cancer Infusion Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Infusion Therapy. This report contains market size and forecasts of Cancer Infusion Therapy in global, including the following market information:
Global Cancer Infusion Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Infusion Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Pharmacies Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Infusion Therapy include Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health and PharMerica, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Infusion Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Infusion Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Infusion Therapy Market Segment Percentages, by Type, 2022 (%)
Pharmacies
Home Health Agencies
Others
Global Cancer Infusion Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Infusion Therapy Market Segment Percentages, by Application, 2022 (%)
Cancer
Chronic Disease
Others
Global Cancer Infusion Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Infusion Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Infusion Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Infusion Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Infusion Therapy, market overview.
Chapter 2: Global Cancer Infusion Therapy market size in revenue.
Chapter 3: Detailed analysis of Cancer Infusion Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Infusion Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Infusion Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Infusion Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Infusion Therapy Overall Market Size
2.1 Global Cancer Infusion Therapy Market Size: 2022 VS 2029
2.2 Global Cancer Infusion Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Infusion Therapy Players in Global Market
3.2 Top Global Cancer Infusion Therapy Companies Ranked by Revenue
3.3 Global Cancer Infusion Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Infusion Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Infusion Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Infusion Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Infusion Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Infusion Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Infusion Therapy Market Size Markets, 2022 & 2029
4.1.2 Pharmacies
4.1.3 Home Health Agencies
4.1.4 Others
4.2 By Type - Global Cancer Infusion Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Infusion Therapy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Infusion Therapy Revenue, 2024-2029
4.2.3 By Type - Global Cancer Infusion Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Infusion Therapy Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Chronic Disease
5.1.4 Others
5.2 By Application - Global Cancer Infusion Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Infusion Therapy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Infusion Therapy Revenue, 2024-2029
5.2.3 By Application - Global Cancer Infusion Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Infusion Therapy Market Size, 2022 & 2029
6.2 By Region - Global Cancer Infusion Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Infusion Therapy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Infusion Therapy Revenue, 2024-2029
6.2.3 By Region - Global Cancer Infusion Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Infusion Therapy Revenue, 2018-2029
6.3.2 US Cancer Infusion Therapy Market Size, 2018-2029
6.3.3 Canada Cancer Infusion Therapy Market Size, 2018-2029
6.3.4 Mexico Cancer Infusion Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Infusion Therapy Revenue, 2018-2029
6.4.2 Germany Cancer Infusion Therapy Market Size, 2018-2029
6.4.3 France Cancer Infusion Therapy Market Size, 2018-2029
6.4.4 U.K. Cancer Infusion Therapy Market Size, 2018-2029
6.4.5 Italy Cancer Infusion Therapy Market Size, 2018-2029
6.4.6 Russia Cancer Infusion Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Infusion Therapy Market Size, 2018-2029
6.4.8 Benelux Cancer Infusion Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Infusion Therapy Revenue, 2018-2029
6.5.2 China Cancer Infusion Therapy Market Size, 2018-2029
6.5.3 Japan Cancer Infusion Therapy Market Size, 2018-2029
6.5.4 South Korea Cancer Infusion Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Infusion Therapy Market Size, 2018-2029
6.5.6 India Cancer Infusion Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Infusion Therapy Revenue, 2018-2029
6.6.2 Brazil Cancer Infusion Therapy Market Size, 2018-2029
6.6.3 Argentina Cancer Infusion Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Infusion Therapy Revenue, 2018-2029
6.7.2 Turkey Cancer Infusion Therapy Market Size, 2018-2029
6.7.3 Israel Cancer Infusion Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Infusion Therapy Market Size, 2018-2029
6.7.5 UAE Cancer Infusion Therapy Market Size, 2018-2029
7 Cancer Infusion Therapy Companies Profiles
7.1 Option Care Health
7.1.1 Option Care Health Company Summary
7.1.2 Option Care Health Business Overview
7.1.3 Option Care Health Cancer Infusion Therapy Major Product Offerings
7.1.4 Option Care Health Cancer Infusion Therapy Revenue in Global Market (2018-2023)
7.1.5 Option Care Health Key News & Latest Developments
7.2 Coram CVS
7.2.1 Coram CVS Company Summary
7.2.2 Coram CVS Business Overview
7.2.3 Coram CVS Cancer Infusion Therapy Major Product Offerings
7.2.4 Coram CVS Cancer Infusion Therapy Revenue in Global Market (2018-2023)
7.2.5 Coram CVS Key News & Latest Developments
7.3 UnitedHealth Group
7.3.1 UnitedHealth Group Company Summary
7.3.2 UnitedHealth Group Business Overview
7.3.3 UnitedHealth Group Cancer Infusion Therapy Major Product Offerings
7.3.4 UnitedHealth Group Cancer Infusion Therapy Revenue in Global Market (2018-2023)
7.3.5 UnitedHealth Group Key News & Latest Developments
7.4 HCA Healthcare
7.4.1 HCA Healthcare Company Summary
7.4.2 HCA Healthcare Business Overview
7.4.3 HCA Healthcare Cancer Infusion Therapy Major Product Offerings
7.4.4 HCA Healthcare Cancer Infusion Therapy Revenue in Global Market (2018-2023)
7.4.5 HCA Healthcare Key News & Latest Developments
7.5 McLaren
7.5.1 McLaren Company Summary
7.5.2 McLaren Business Overview
7.5.3 McLaren Cancer Infusion Therapy Major Product Offerings
7.5.4 McLaren Cancer Infusion Therapy Revenue in Global Market (2018-2023)
7.5.5 McLaren Key News & Latest Developments
7.6 CHI Health
7.6.1 CHI Health Company Summary
7.6.2 CHI Health Business Overview
7.6.3 CHI Health Cancer Infusion Therapy Major Product Offerings
7.6.4 CHI Health Cancer Infusion Therapy Revenue in Global Market (2018-2023)
7.6.5 CHI Health Key News & Latest Developments
7.7 Accredo Health
7.7.1 Accredo Health Company Summary
7.7.2 Accredo Health Business Overview
7.7.3 Accredo Health Cancer Infusion Therapy Major Product Offerings
7.7.4 Accredo Health Cancer Infusion Therapy Revenue in Global Market (2018-2023)
7.7.5 Accredo Health Key News & Latest Developments
7.8 PharMerica
7.8.1 PharMerica Company Summary
7.8.2 PharMerica Business Overview
7.8.3 PharMerica Cancer Infusion Therapy Major Product Offerings
7.8.4 PharMerica Cancer Infusion Therapy Revenue in Global Market (2018-2023)
7.8.5 PharMerica Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Infusion Therapy Market Opportunities & Trends in Global Market
Table 2. Cancer Infusion Therapy Market Drivers in Global Market
Table 3. Cancer Infusion Therapy Market Restraints in Global Market
Table 4. Key Players of Cancer Infusion Therapy in Global Market
Table 5. Top Cancer Infusion Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Infusion Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Infusion Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Infusion Therapy Product Type
Table 9. List of Global Tier 1 Cancer Infusion Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Infusion Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Infusion Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Infusion Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Infusion Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Infusion Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Infusion Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Infusion Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Infusion Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Infusion Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Infusion Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Infusion Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Infusion Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Infusion Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Infusion Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Infusion Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Option Care Health Company Summary
Table 31. Option Care Health Cancer Infusion Therapy Product Offerings
Table 32. Option Care Health Cancer Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Option Care Health Key News & Latest Developments
Table 34. Coram CVS Company Summary
Table 35. Coram CVS Cancer Infusion Therapy Product Offerings
Table 36. Coram CVS Cancer Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Coram CVS Key News & Latest Developments
Table 38. UnitedHealth Group Company Summary
Table 39. UnitedHealth Group Cancer Infusion Therapy Product Offerings
Table 40. UnitedHealth Group Cancer Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. UnitedHealth Group Key News & Latest Developments
Table 42. HCA Healthcare Company Summary
Table 43. HCA Healthcare Cancer Infusion Therapy Product Offerings
Table 44. HCA Healthcare Cancer Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. HCA Healthcare Key News & Latest Developments
Table 46. McLaren Company Summary
Table 47. McLaren Cancer Infusion Therapy Product Offerings
Table 48. McLaren Cancer Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. McLaren Key News & Latest Developments
Table 50. CHI Health Company Summary
Table 51. CHI Health Cancer Infusion Therapy Product Offerings
Table 52. CHI Health Cancer Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. CHI Health Key News & Latest Developments
Table 54. Accredo Health Company Summary
Table 55. Accredo Health Cancer Infusion Therapy Product Offerings
Table 56. Accredo Health Cancer Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Accredo Health Key News & Latest Developments
Table 58. PharMerica Company Summary
Table 59. PharMerica Cancer Infusion Therapy Product Offerings
Table 60. PharMerica Cancer Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. PharMerica Key News & Latest Developments
List of Figures
Figure 1. Cancer Infusion Therapy Segment by Type in 2022
Figure 2. Cancer Infusion Therapy Segment by Application in 2022
Figure 3. Global Cancer Infusion Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Infusion Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Infusion Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Infusion Therapy Revenue in 2022
Figure 8. By Type - Global Cancer Infusion Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Infusion Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Infusion Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Infusion Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Infusion Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Infusion Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Infusion Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Infusion Therapy Revenue Market Share, 2018-2029
Figure 16. US Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Infusion Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Infusion Therapy Revenue Market Share, 2018-2029
Figure 28. China Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Infusion Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Infusion Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Infusion Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Option Care Health Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Coram CVS Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. UnitedHealth Group Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. HCA Healthcare Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. McLaren Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. CHI Health Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Accredo Health Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. PharMerica Cancer Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
